Prevalence, Detection and Treatment of Hepatitis in Kurdistan Region

posted Feb 26, 2020, 3:48 AM by   [ updated Feb 26, 2020, 5:24 AM ]

Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-saving drugs for viral hepatitis. Signed by over 120 organizations from 55 countries, the letter highlights that more people die each year from hepatitis B and C than from HIV/AIDS, TB or malaria and that “the single most important reason for this is that they do not have access to life-saving drugs for hepatitis B and hepatitis C “.


The open letter has been signed on behalf of the 400 million people worldwide living with hepatitis B and C and makes specific requests to governments and pharmaceutical companies. In particular, the letter calls on national governments to take all necessary steps to:

  • Remove stigma that prevents people coming forward for testing

  • Put in place adequate infrastructure and reduce the price of diagnostics so that they can screen at-risk populations

By Prof. Seyed Moayed Alavian M.D.

and Assistant Prof. Salman Khan

This workshop is arranged by KNU’s

Center for Academic Research, Training and Activities (CART)


22th April 2020, at 10:00

KNU Conference Hall

Please click to register to attend this International Workshop

Please read further about this workshop below or download the full flyer in PDF at the the bottom of this page.